1. Home
  2. ORIC vs SPH Comparison

ORIC vs SPH Comparison

Compare ORIC & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • SPH
  • Stock Information
  • Founded
  • ORIC 2014
  • SPH 1945
  • Country
  • ORIC United States
  • SPH United States
  • Employees
  • ORIC N/A
  • SPH N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • SPH Other Specialty Stores
  • Sector
  • ORIC Health Care
  • SPH Consumer Discretionary
  • Exchange
  • ORIC Nasdaq
  • SPH Nasdaq
  • Market Cap
  • ORIC 1.1B
  • SPH 1.2B
  • IPO Year
  • ORIC 2020
  • SPH 1996
  • Fundamental
  • Price
  • ORIC $12.96
  • SPH $18.29
  • Analyst Decision
  • ORIC Strong Buy
  • SPH
  • Analyst Count
  • ORIC 8
  • SPH 0
  • Target Price
  • ORIC $16.57
  • SPH N/A
  • AVG Volume (30 Days)
  • ORIC 1.5M
  • SPH 86.0K
  • Earning Date
  • ORIC 11-06-2025
  • SPH 11-13-2025
  • Dividend Yield
  • ORIC N/A
  • SPH 7.11%
  • EPS Growth
  • ORIC N/A
  • SPH N/A
  • EPS
  • ORIC N/A
  • SPH 1.49
  • Revenue
  • ORIC N/A
  • SPH $1,429,783,000.00
  • Revenue This Year
  • ORIC N/A
  • SPH $10.99
  • Revenue Next Year
  • ORIC N/A
  • SPH N/A
  • P/E Ratio
  • ORIC N/A
  • SPH $12.28
  • Revenue Growth
  • ORIC N/A
  • SPH 6.29
  • 52 Week Low
  • ORIC $3.90
  • SPH $16.92
  • 52 Week High
  • ORIC $14.93
  • SPH $22.24
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 53.61
  • SPH 40.79
  • Support Level
  • ORIC $11.71
  • SPH $18.75
  • Resistance Level
  • ORIC $13.80
  • SPH $19.02
  • Average True Range (ATR)
  • ORIC 0.69
  • SPH 0.34
  • MACD
  • ORIC -0.11
  • SPH -0.01
  • Stochastic Oscillator
  • ORIC 50.63
  • SPH 20.10

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About SPH Suburban Propane Partners L.P.

Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.

Share on Social Networks: